Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative TP73 transcript analysis in hepatocellular carcinomas.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jan 2004

Stiewe Thorsten, Tuve Sebastian, Peter Martin, Tannapfel Andrea, Elmaagacli Ahmet H, Pützer Brigitte M

Abstract excerpt

PURPOSE: The p53 family member p73 displays significant homology to p53, but data from primary tumors demonstrating increased expression levels of p73 in the absence of any gene mutations argue against a classical tumor suppressor function. A detailed analysis of the p73 protein in tumor tissues...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Genes, Tumor Suppressor
Share to Loss of Heterozygosity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Isoforms

Share to RNA Splicing

Share to Transcriptional Activation

Share to Tumor Protein p73

Source

Identifiers

PMID: 14760085
DOI: 10.1158/1078-0432.ccr-0153-03

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-14760085-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative TP73 transcript analysis in hepatocellular carcinomas.PMID 14760085Read ↗

ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondriaSemantic proximity Read ↗

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.Semantic proximity Read ↗

Clinical implications of the deregulated TP73 isoforms expression in cancerSemantic proximity Read ↗

ΔTAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1Semantic proximity Read ↗

Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in VivoSemantic proximity Read ↗

p73: in silico evidence for a putative third promoter region.Semantic proximity Read ↗

Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.Semantic proximity Read ↗

Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.Semantic proximity Read ↗

Two new p73 splice variants, gamma and delta, with different transcriptional activity.Semantic proximity Read ↗

The role of the TP73 gene and its transcripts in neuro-oncology.Semantic proximity Read ↗

deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.Semantic proximity Read ↗

Tissue-specific expression of p73 and p63 isoforms in human tissuesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.